Poster Abstract Session:
207. Treatment of HAI/MDRO
Saturday, October 20, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: A. Antimicrobial Agents

Tracks: Epidemiology and Infection Control

Presentations:

Clinical Microbial and Molecular characterization of Bacteremia due to Carbapenemase-producing Klebsiella pneumoniae (KPC)
Jae H. Hong, MD ; Cornelius Clancy, MD ; Ryan K. Shields, PharmD ; Yohei Doi, MD, PhD ; Liang Chen, PhD ; Yanan Zhao, PhD ; Barry Kreiswirth, PhD ; Minh-Hong Nguyen, MD

Outcomes of Polymyxin B Monotherapy for the Treatment of Carbapenem-resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya, PharmD ; Ting-Yi Chen, MD, MPH ; Marco Scipione, PharmD ; Diana Esaian, PharmD ; Michael S. Phillips, MD ; John Papadopoulos, PharmD ; Sapna A. Mehta, MD
Posters
  • Polymyxin poster final.pdf (678.3 kB)

  • Hematologic and renal function evaluation of linezolid and vancomycin in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA): results from the IMPACT-HAP study
    Kimbal D. Ford, PharmD ; Paula Peyrani, MD ; Timothy L. Wiemken, PhD, MPH, CIC ; Ernesto G. Scerpella, MD ; Marcus Zervos, MD ; Daniel H. Kett, MD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP ; Gary E. Stein, PharmD ; Julio A. Ramirez, MD

    Tigecycline for Severe Clostridium difficile Infection
    Ashley Thomas, MD ; Farhan Khan, MD ; Mark R. Wallace, MD

    Neutropenia Associated with Prolonged Daptomycin Use
    BM Knoll, MD, PhD ; PJ Spieler, MD ; David Kubiak, PharmD ; Francisco Marty, MD

    Empiric Therapy for Gram-Negative Urinary Tract Infections and UTI-Associated Bacteremia at a Multi-Site Academic Medical Center
    Jonathan Faldasz, PharmD ; Charles James, PharmD ; Michele Ritter, MD ; Yuerong Zhuang, MS ; Judy Hsiao, PharmD ; Francesca Torriani, MD

    Treatment and Outcomes of Stenotrophomonas maltophilia Bloodstream Infections (BSI)
    Andrew S. Hunter, PharmD ; Jennifer Sekeres, PharmD ; Simon Lam, PharmD ; Gerri S. Hall, PhD ; David van Duin, MD, PhD ; Elizabeth A. Neuner, PharmD

    Resource utilization in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) treated with linezolid versus vancomycin: results from the IMPACT-HAP study
    Timothy L. Wiemken, PhD, MPH, CIC ; Paula Peyrani, MD ; Kimbal D. Ford, PharmD ; Ernesto G. Scerpella, MD ; Marcus Zervos, MD ; Daniel H. Kett, MD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP ; Gary E. Stein, PharmD ; Julio A. Ramirez, MD

    Evaluation of Vancomyin Induced Neutropenia at UC San Diego Health System
    Katherine Gazlay, PharmD ; Michele Ritter, MD ; James Lane, PharmD ; Jenny Tran ; Charles James, PharmD

    Treatment of infections by KPC-producing Enterobacteriaceae
    Maura Oliveira ; Denise Assis ; Gladys Prado, MD ; Maristela Freire, MSc ; Jessica Ramos, MD ; Anna Machado ; Helio Caiaffa, Phd ; Anna Levin
    Posters
  • poster SHEA 2012-KPC.pdf (310.4 kB)

  • Specimen Type and Unit Specific Antibiograms to Guide Empiric Antimicrobial Therapy
    Christina Rivera, PharmD ; Ritu Banerjee, MD, PhD ; John Wilson, MD ; Lynn Estes, PharmD

    An electronic medical record order set improves adherence to urinary tract infection treatment guidelines in the emergency department without improving diagnostic accuracy
    Michelle T. Hecker, MD ; Clinton Fox ; Rita Cydulka, M.D ; Jonathan Siff, M.D ; Charles Emerman, M.D ; Ajay K. Sethi, PhD ; Christine Muganda, B.S ; Curtis J. Donskey, MD

    Incidence of Renal Failure and Associated Economic Burden Among Patients with Nosocomial Pneumonia Caused by Methicillin Resistant Staphylococcus Aureus (MRSA-NP) Treated with Linezolid or Vancomycin: A Secondary Analysis of A Multi-center Randomized Double-Blind Clinical Trial
    Michael Niederman, MD ; Jean E. Chastre, MD ; Caitlyn Solem, PhD ; Yin Wan, MS ; Xin Gao, PhD ; Daniela E. Myers, MPH ; Seema Haider, MSc ; Richard Chambers, MSPH ; Jim Li, MD, PhD ; Ben A Van Hout, PhD ; Jennifer Stephens, PharmD, BCPS

    Relationship Between Varying Daptomycin MICs and Outcomes in Enterococcal Bacteremia
    Sharon Sam, PharmD ; Jessica Clark, PharmD, BCPS ; Allyson Greenberg, PharmD Candidate ; Carrie Sincak, PharmD, BCPS ; Zakir Hussain Shaikh, MD, MPH, CPE, FIDSA ; Edward Dominguez, MD, FACP, FIDSA

    Clinical outcomes and the related risk factors in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin in Korea: A prospective multicenter observational study
    Young Kyung Yoon, M.D., Ph.D. ; Dae Won Park, MD ; Hyo Youl Kim, MD, PhD ; Shin-Woo Kim, MD ; Chang Seop Lee, MD ; Hee-Chang Jang, MD ; Cheol-In Kang, MD ; Yeon-Sook Kim, MD ; Eu Suk Kim ; Mi Suk Lee, MD ; Seong Yeol Ryu, M.D ; Young Joo Choi, M.D., Ph.D ; Seung Soon Lee, M.D. ; Hee Jung Choi, MD ; Sang Il Kim, MD ; Jeong Yeon Kim, M.D., Ph.D. ; Kyong Ran Peck, MD, PhD ; Min-Ja Kim, Professor

    Mortality associated with bacteraemia due to extended-spectrum beta-lactamase (ESBL) producing E.coli in a German university hospital
    Rasmus Leistner, MD ; Elisabeth Meyer, MD, PhD ; Frank Schwab, MSc ; Christian Sakellariou, MD ; Michael Behnke, MSc ; Sebastian Kruse, M.Sc. ; Petra Dem, RN ; Petra Gastmeier, MD

    Risk Factors Associated with Blood Stream Infection (BSI) due to relatively Susceptible Strains (SS) of Acinetobacter baumannii (AB) - A Matched Case-Control Study
    Indu K. Chalana, MD ; Naomi J. Davis, MPH ; Dror Marchaim, MD ; Paul Johnson, MD ; Ryan Tansek, BS ; Khawar Chaudhry, BS ; Namir Khandker, BS ; Paul Lephart, PhD ; Jessica Slim, MD ; Jatinder Hothi, MD ; Jason Pogue, PharmD ; Jing J. Zhao, PharmD ; Sorabh Dhar, MD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH
    Posters
  • IDSA AB MDR Poster- FINAL.pdf (313.2 kB)
  • CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.